About Messe München International (MMI)


Published on

Published in: Economy & Finance, Business
  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

About Messe München International (MMI)

  1. 1. No. 12 / February 2008 Bring start-ups together with investors analytica 2008: Finance Day celebrates premiere An information platform developed especially for new life-science companies will be celebrating a premiere at this year's analytica: Finance Day on April 4th will feature an extensive program of lectures and forums where prominent speakers will introduce new companies to the topic of financing, inform them about promotion programs and give them practical tips for approaching investors. As the leading international trade fair for analysis, laboratory technology and biotechnology, analytica 2008 from April 1 – 4 will pay special attention to the financing needs of new biotech companies. Munich, February 12, 2008 – The German biotechnology sector reached a new level of development in 2006. According to the results of a 2007 survey of biotech companies conducted on behalf of Germany's Federal Ministry of Education and Research (BMBF), both the number of jobs and sales increased considerably over 2005. During 2006, surveyed companies invested more than 970 million euros in research and development, which was 36 percent more than the previous year. The industry is in the midst of an upswing – and depends on venture capital. Finance Day at analytica 2008 will focus on this situation and give scientists and company founders in the life-science sector a platform for networking with investors. Finance Day will mediate between companies looking for capital and those that have capital available. After all, in many cases company founders do not know how to approach potential investors. In contrast, companies that have capital are not always in a position to evaluate the scientific impact of the ideas they are presented and find it difficult to assess their economic potential. Therefore, the most important
  2. 2. 2 objective of this event is to promote dialog between the scientific sector and providers of capital. Finance Day is being held at the Innovations & Technology Forum, which is located in the InnovationsArea in Hall A3. There will be four blocks on specific themes, i.e. "Early-phase financing", "Venture capital", "Joint ventures: Big pharma/chemical industry & biotech" and "Life-science companies listed on the stock exchange". The lectures and the discussions that follow them will give participants valuable information about financing to start new companies and expand existing ones. Speakers will include company representatives as well as business angels and capital providers. Presentations begin at 10 a.m. on Friday, April 4, 2008 and continue the entire day until 5 p.m. • "High-tech founder's funds and business angels – An ice-breaker for life- science start-ups?" is the title of a discussion about various models for early- phase financing. Participants will include - Prof. Horst Domdey - Marco Winzer, Senior Investment Manager/Authorized Signatory, High- Tech-Gründerfonds - Dr. Hellmut Kirchner, Founding Partner, VCM Capital Management GmbH - Dr. Andreas Jenne, CEO & Founder, Kinaxo Biotechnologies GmbH. - Dr. Uwe Gerlach, Sanofi-Aventis Deutschland GmbH (Science4Life) • The following experts will hold a discussion on "Venture capital: financing partners for biotech and medical-technology companies" (in English): - Dr. Hubert Birner, General Partner, TVM Capital GmbH - Dr. Holger Reithinger, Partner, The Global Life Science Ventures GmbH - Dr. Alexander Asam, Investment Consultant, HBM Partners AG - Joerg Ritter, Partner, Holme, Roberts & Owen LLP • The panel discussions Cooperations Big Pharma / Chemical Industry & Biotech includes lectures of:
  3. 3. 3 - Dr. Anton Haselbeck, Leiter Pharma New Technologies, Roche Diagnostics GmbH (Penzberg) - Dr. André Koltermann, Süd-Chemie AG - Dr. Kerstin Walke, Bereich Biopharmaceuticals, Boehringer Ingelheim GmbH - Dr. Frank Morich, CEO, Noxxon Pharma AG - Peter Homberg, Partner, Leiter Life Science Team Deutschland, Jones Day • Life-science companies listed on the stock exchange will report on their experiences and discuss the "Opportunities and risks from the perspective of businessmen and investors". The panel will include - Dr. Jan zur Hausen, Sal. Oppenheim jr. & Cie. KGaA - Dr. Hanns Frohnmeyer, Head of Life Science Senior Equity Analyst Healthcare / Biotechnology, Landesbank Baden-Württemberg - Alexander von Gabain, CSO und Gruender, Intercell AG, tba - Jens Schneider-Mergener, Chairman of the Board, Jerini AG - Peter Llewellyn-Davies, CFO, Wilex AG - Klaus Maleck, CFO, Evotec AG The panel discussions will be rounded out by half-hour lectures, many of them by renowned experts in the biotech and venture-capital sector. They include Prof. Horst Domdey Bio M Biotech Cluster Development GmbH, Dr. Peter Heinrich, Chairman of the Board, BIO Deutschland e.V. / Chairman of the Board, Medigene AG, Dr. Hubert Birner, General Partner, TVM Capital GmbH, Peter Homberg, Partner, Leiter Life Science Team Deutschland, Jones Day, Dr. Holger Zinke, Vorstandsvorsitzender, Brain AG, Dr. Holger Zinke, Chairman of the Board, Brain AG and Holger Hinz from Quirin Bank. Finance Day is being organized by GoingPublic Media AG, which was founded in 1998. It is considered one of Germany's leading publishers of trade journals on the topic of company financing, technology and investments/stock exchange. In addition to its monthly "GoingPublic Magazin" and its special supplements, the publisher's other periodicals include "VentureCapital Magazin", which gives investors a look at
  4. 4. 4 market developments, competition and trends and familiarizes entrepreneurs with all aspects of private-equity financing. A detailed agenda for Finance Day including speakers, topics and times will be available for download from the event database at the analytica homepage as of February 15: www.analytica.de/programm ### About analytica analytica, which includes the Analytica Conference, is the leading European trade fair for analysis, laboratory technology, biotechnology/life sciences, diagnostics and data and process management. It is held in Munich, the leading trade-fair venue and business location in the world. Visitors include decision-makers and users from the chemical, medical and pharmaceutical sectors as well as industrial and government research organizations. Analytica is held every two years and has established itself as a central marketplace for marketable products and solutions as well as innovations. The 21st analytica is being held at the New Munich Trade Fair Centre from April 1 – 4, 2008. Some 1,000 exhibitors and 30,000 visitors from around the world are expected. Approximately one-third of all visitors are from abroad. analytica is part of an international network of trade fairs: It includes the trade fairs analytica, analytica China (Shanghai, Sept. 23 - 25, 2008) and analytica Anacon India (Hyderabad, autumn 2009). Additional information about the fair(s) and the program of events is available on the Internet at www.analytica.de. About Messe München International (MMI) Messe München International (MMI, Munich Trade Fairs International Group) is one of the world´s leading trade-fair companies. It organises around 40 trade fairs for capital and consumer goods, and key high-tech industries. Each year over 30,000 exhibitors from more than 100 countries, and over two million visitors from more than 200 countries take part in the events in Munich. In addition, MMI organises trade fairs in Asia, Russia, the Middle East and South America. With six subsidiaries abroad - in Europe and in Asia - and with 66 foreign representatives serving 89 countries, MMI has a truly global network. Contact for journalists Ellen Richter-Maierhofer Pressereferat analytica Tel.: +49 (0) 89/949-20650, E-Mail: ellen.richter-maierhofer@messe-muenchen.de